verekitug
verekitug: sourced relationships with 1 company · 4 clinical trials tracked.
verekitug evidence translation
What we can confirm
4 tracked trials
What it means
What to watch
Prepared research question
How could verekitug → UPB affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence4 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Upstream Bio, Inc. (UPB) Chronic Obstructive Pulmonary Disease; Severe Asthma; Chroni… | Phase 2 |
Clinical Trial Registry Records (4)
A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel-Group Study to Assess Efficacy and Safety of Verekitug (UPB-101) in Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Primary endpoint: Annualized rate of moderate or severe COPD exacerbation events
A Long-Term Extension Study to Evaluate Safety and Efficacy of Verekitug (UPB-101) in Adult Participants With Severe Asthma Who Completed the VALIANT Trial
Primary endpoint: Number of Participants with Adverse Events (AEs) and Serious Adverse Events (SAEs)
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center, Dose-ranging Study to Evaluate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)
Primary endpoint: Annual Asthma Exacerbation Rate (AAER)
A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps on a Background of Nasal Corticosteroids (VIBRANT)
Primary endpoint: Change From Baseline in Nasal Polyp Score (NPS) at Week 24
Frequently asked questions
Which companies have sourced relationships with verekitug?
verekitug has dated SEC/FDA relationship records for Upstream Bio, Inc..
How many clinical trials involve verekitug?
BioSniper tracks 4 clinical trials involving verekitug.